INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.320
-0.010 (-0.75%)
At close: Mar 9, 2026, 4:00 PM EDT
1.310
-0.010 (-0.76%)
After-hours: Mar 9, 2026, 4:00 PM EDT
INmune Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.05 | 0.01 | 0.16 | 0.37 | 0.18 | 0.01 | |
| Revenue Growth (YoY) | 19.05% | -90.97% | -58.56% | 106.63% | 1545.45% | - | |
| Gross Profit | 0.05 | 0.01 | 0.16 | 0.37 | 0.18 | 0.01 | |
| Selling, General & Admin | 9.34 | 9.48 | 9.62 | 9.26 | 8.79 | 6.32 | |
| Research & Development | 25.57 | 33.17 | 20.27 | 17.07 | 20.54 | 5.92 | |
| Operating Expenses | 34.91 | 42.65 | 29.9 | 26.33 | 29.33 | 12.24 | |
| Operating Income | -34.86 | -42.64 | -29.74 | -25.95 | -29.15 | -12.23 | |
| Interest Expense | -0.04 | -0.79 | -2.28 | -2.01 | - | - | |
| Interest & Investment Income | 1.3 | 0.7 | - | - | - | - | |
| Other Non Operating Income (Expenses) | -0.37 | 0.64 | 2.01 | 0.67 | -1.19 | 0.03 | |
| EBT Excluding Unusual Items | -33.97 | -42.08 | -30.01 | -27.3 | -30.34 | -12.2 | |
| Other Unusual Items | 0.6 | - | - | - | - | 0.1 | |
| Pretax Income | -49.89 | -42.08 | -30.01 | -27.3 | -30.34 | -12.1 | |
| Net Income | -49.89 | -42.08 | -30.01 | -27.3 | -30.34 | -12.1 | |
| Net Income to Common | -49.89 | -42.08 | -30.01 | -27.3 | -30.34 | -12.1 | |
| Shares Outstanding (Basic) | 24 | 20 | 18 | 18 | 16 | 12 | |
| Shares Outstanding (Diluted) | 24 | 20 | 18 | 18 | 16 | 12 | |
| Shares Change (YoY) | 25.30% | 10.92% | 0.30% | 11.14% | 34.55% | 16.70% | |
| EPS (Basic) | -2.11 | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 | |
| EPS (Diluted) | -2.11 | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -69724.00% | -304535.71% | -19187.74% | -6938.77% | -16106.63% | -111163.64% | |
| Profit Margin | -99774.00% | -300585.71% | -19360.00% | -7299.20% | -16762.43% | -109990.91% | |
| EBIT | -34.86 | -42.64 | -29.74 | -25.95 | -29.15 | -12.23 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.